Despite the potential of tapping Chinese investors by U.S. fund managers, there is still disconnect between the two camps’ demands and expectations, said head of placement agent MVision. Please login/register to view this content.
Last week, Chinese drug maker Harbin Pharmaceutical Group made headlines by announcing a $300 million investment in GNC, throwing the struggling supplements company a much-needed lifeline. Please login/register to view this content.
Clearwater Capital Partners, a pan-Asia focused credit investment firm, has passed the halfway mark of its latest commingled fund, said co-founder and Managing Partner Robert Petty. Please login/register to view this content.